$THRM

Gentherm (THRM) Stock Faces 1.7% Net Margin Strain Challenging Bullish Growth Narrative

Simply Wall St reports Gentherm (THRM) Q2 2026 revenue of $416.2m and basic EPS of $0.14. Trailing 12-month revenue is $1.58b with basic EPS $0.87 and a net margin of 1.7%, down from 2.2% a year earlier, after a $25.1m one-off loss. Shares trade at a trailing P/E of 49.3x versus peers 16.4x-20.6x.

Original reporting
Published Jul 24, 2026, 11:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 4:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gentherm (THRM) Stock Faces 1.7% Net Margin Strain Challenging Bullish Growth Narrative — source image
Decision brief

The 30-second read

$THRMBearishLow
01

Why it matters

The key trading takeaway is the mismatch between top-line growth and weak trailing net margin, which can justify multiple compression when expectations are already high.

02

Market read

For THRM, the article highlights margin pressure (1.7% net margin) and a high trailing P/E (49.3x), challenging the bullish growth narrative.

03

What to watch

The article references a prior one-off loss but does not quantify current cost structure changes or segment profitability, so the sustainability of the 1.7% margin is not fully evidenced here.

Relevance 4/10Novelty 4/10Timing: post-Q2 2026 scorecard framing for margin and valuation

Background

The article summarizes Gentherm’s Q2 2026 results and compares trailing profitability and valuation to prior-year levels and peers.

Company-level read

Ticker impact

$THRMBearishMedium confidence
Context

Gentherm reports Q2 2026 revenue of $416.2M and trailing net margin of 1.7%, down from 2.2% a year earlier.

Expected impact

Near-term downside bias versus valuation if investors treat the 1.7% net margin as persistent rather than temporary.

Evidence & confidence

The article’s newest concrete datapoints are the Q2 2026 scorecard and the trailing 12-month net margin (1.7% vs 2.2% prior year), alongside valuation metrics (49.3x trailing P/E). That combination typically pressures multiples when margins are not improving.

Market effects

Auto components investors may re-focus on profitability durability, not just revenue growth, for thermal management and comfort systems suppliers.

No specific regional catalyst beyond US-listed company fundamentals.

Limited, as the piece is company-specific and does not cite global regulatory or demand shocks.

Counterpoint

Revenue growth (12.6% YoY) and a higher DCF fair value versus the current price suggest the market may be underpricing a future margin recovery.

Key entities

  • Gentherm

    US-listed auto components supplier reporting Q2 2026 scorecard and trailing net margin of 1.7%.

  • Simply Wall St

    Publishes fundamental commentary using historical data and analyst forecasts.

Related articles

$THRMMed

Gentherm (THRM) details Modine spin-off merger, $3.5B 2030 revenue target

Gentherm (THRM) plans a Reverse Morris Trust business combination with Modine’s Performance Technologies division (SpinCo). The deal would create a $2.6B revenue company with EBITDA margins above 12% and under 70% light-vehicle exposure. Gentherm targets $3.5B revenue and over $0.5B EBITDA by 2030, including about $100M cross-selling synergies, pending a Sept. 10 vote and IRS ruling.

$THRMMed

Gentherm Incorporated (THRM) outlines Reverse Morris Trust deal with Modine

Gentherm (THRM) and Modine are progressing a Reverse Morris Trust to combine Modine’s Performance Technologies business with Gentherm. Modine formed Platinum SpinCo, transferred the assets, and will distribute SpinCo shares to Modine holders. After distribution, SpinCo merges into Gentherm’s subsidiary. Target ownership is about 40%/60%, with an exchange ratio adjustable to meet tax needs. Illustrative merger consideration is ~20.85M Gentherm shares (~$882M) plus a planned $210M SpinCo cash dist

$THRMMed

Gentherm Incorporated Q2 2026 Earnings Call Summary

Gentherm reported Q2 2026 results and an earnings-call outlook. It cited 12.7% organic automotive growth versus a 3% global light-vehicle production decline, FDA 510(k) clearance for ThermAffyx, and an IME acquisition to access VA hospitals. Gentherm expects the Modine Performance Technologies merger to close in early Q4 2026, targeting $3.5B revenue by 2030, $400M buyback, and $800M committed financing.

$THRMHighAI 9/10

Gentherm (THRM) Q2 2026 Earnings Call Transcript

Gentherm (THRM) reported Q2 2026 product revenue of $416 million, up 11% year over year, with 9.5% organic growth. Automotive climate and comfort revenue rose 14.1% (12.7% ex FX). Adjusted EBITDA was $48.8 million and non-GAAP EPS $0.75. The company raised 2026 guidance to $1.6 billion revenue and $185-$200 million adjusted EBITDA, and authorized $400 million in buybacks.

$THRMMedAI 8/10

Gentherm Q2 Earnings Call Highlights

Gentherm (NASDAQ:THRM) reported adjusted EBITDA of $48.8M (11.7% of sales) and adjusted EPS of $0.75 for Q2. Management cited margin pressure from timing, inventory reductions and warranty accruals. Gentherm raised 2026 guidance to $1.6B revenue and $185M-$200M adjusted EBITDA, and expects ThermAffyx initial sales in Q3.